Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China · Delayed Price · Currency is CNY 170.00
-0.44 (-0.26%)
At close: Feb 6, 2026
SHA:600436 Revenue
Zhangzhou Pientzehuang Pharmaceutical., had revenue of 2.06B CNY in the quarter ending September 30, 2025, a decrease of -26.28%. This brings the company's revenue in the last twelve months to 9.78B, down -10.35% year-over-year. In the year 2024, Zhangzhou Pientzehuang Pharmaceutical., had annual revenue of 10.79B with 7.25% growth.
Revenue (ttm)
9.78B
Revenue Growth
-10.35%
P/S Ratio
10.49
Revenue / Employee
3.44M
Employees
2,839
Market Cap
102.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.79B | 729.37M | 7.25% |
| Dec 31, 2023 | 10.06B | 1.36B | 15.69% |
| Dec 31, 2022 | 8.69B | 672.45M | 8.38% |
| Dec 31, 2021 | 8.02B | 1.51B | 23.20% |
| Dec 31, 2020 | 6.51B | 788.51M | 13.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 53.89B |
| Zhejiang Int'l Group | 33.54B |
| Sichuan Kelun Pharmaceutical | 18.30B |
| Yifan Pharmaceutical | 5.22B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 2.81B |
| GuangYuYuan Chinese Herbal Medicine | 1.39B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.05B |
| Shanghai InnoStar Bio-tech | 829.92M |